Report : Europe Medical Terahertz Technology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Terahertz Imaging and Terahertz Spectroscopy) and Application (Oncology, Dentistry, Dermatology, Tomography, Biochemistry, and Others)
At 16.9% CAGR, the Europe Medical Terahertz Technology Market is speculated to be worth US$ 101.84 Million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Europe medical terahertz technology market was valued at US$ 39.90 million in 2022 and is expected to reach US$ 101.84 million by 2028, registering a CAGR of 16.9% from 2022 to 2028. Rising demand for non-invasive technique for early detection of cancer and increasing use of terahertz technology in dental care are the critical factors attributed to the Europe medical terahertz technology market expansion.
Since terahertz radiation can distinguish between different tooth layers, it is employed in dentistry. Terahertz imaging can detect dental caries in its earliest stages and flaws in tooth structure without creating an ionization risk as X-rays do. THz rays are considered biologically harmless and the future of diagnosis in the dental and medical industries because they have no negative effects. THz pulse imaging may be used to provide useful diagnostic data relating to enamel, dentine, and pump cavity, according to recent scientific research evidence. According to many studies, the time-of-flight of THz pulses through the tooth enables extremely significant measurements of things such as enamel thickness. It can also produce a picture that displays the enamel and dentine. Additionally, pulp cavity locations can be located using THz pulse absorption in the tooth, allowing a dentist to determine the best course of action. Thus, using terahertz technology in dental care is driving the Europe medical terahertz technology market growth.
On the contrary, challenges related to imaging resolution hurdles the growth of Europe medical terahertz technology market.
Based on type, the Europe medical terahertz technology market is segmented into terahertz imaging and terahertz spectroscopy. The terahertz imaging segment held 81.2% market share in 2022, amassing US$ 32.41 million. It is projected to garner US$ 81.77 million by 2028 to expand at 16.7% CAGR during 2022–2028.
Based on application, the Europe medical terahertz technology market is segmented into oncology, dentistry, dermatology, tomography, biochemistry, and others. The oncology segment held 50.2% market share in 2022, amassing US$ 20.02 million. It is projected to garner US$ 54.09 million by 2028 to expand at 18.0% CAGR during 2022–2028.
Based on country, the Europe medical terahertz technology market is segmented into France, Germany, Italy, Spain, the UK, Russia, and the Rest of Europe. Our regional analysis states that Germany captured 24.2% market share in 2022. It was assessed at US$ 9.67 million in 2022 and is likely to hit US$ 24.95 million by 2028, exhibiting a CAGR of 17.1% during the forecast period.
Key players dominating the Europe medical terahertz technology market are Acal BFi Limited; Advantest Corporation; HÜBNER GmbH & Co. KG; Luna Innovations Inc.; Menlo Systems GmbH; Microtech Instrument Inc.; Terasense Group Inc.; Teraview limited; and Toptica Photonics AG, among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org